Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Operating Leases (2019 - 2026)

OptimizeRx's Operating Leases history spans 7 years, with the latest figure at $234000.0 for Q4 2025.

  • On a quarterly basis, Operating Leases rose 11.96% to $234000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $234000.0, a 11.96% increase, with the full-year FY2025 number at $234000.0, up 11.96% from a year prior.
  • Operating Leases hit $234000.0 in Q4 2025 for OptimizeRx, down from $300000.0 in the prior quarter.
  • Over the last five years, Operating Leases for OPRX hit a ceiling of $548000.0 in Q2 2025 and a floor of $14019.0 in Q2 2023.
  • Historically, Operating Leases has averaged $242827.2 across 5 years, with a median of $239363.0 in 2021.
  • Biggest five-year swings in Operating Leases: tumbled 92.61% in 2023 and later skyrocketed 1833.09% in 2024.
  • Tracing OPRX's Operating Leases over 5 years: stood at $236726.0 in 2021, then tumbled by 38.95% to $144532.0 in 2022, then surged by 156.69% to $371000.0 in 2023, then tumbled by 43.67% to $209000.0 in 2024, then rose by 11.96% to $234000.0 in 2025.
  • Business Quant data shows Operating Leases for OPRX at $234000.0 in Q4 2025, $300000.0 in Q3 2025, and $548000.0 in Q2 2025.